Joanne Berger-Sweeney | |
|---|---|
.jpg) Berger-Sweeney in 2012 | |
| 22nd President of Trinity College | |
| Assumed office October 26, 2014 | |
| Preceded by | James F. Jones Jr. |
| Personal details | |
| Born | Joanne Sweeney September 21, 1958 Los Angeles, California, U.S. |
| Education | Wellesley College (BA) University of California, Berkeley (MPH) Johns Hopkins University (PhD) |
| Known for | Galantamine proof of concept |
| Spouse | Urs Berger |
| Children | 2 |
| Scientific career | |
| Fields | Neuroscience |
| Institutions | Trinity College (Connecticut) |
| Doctoral advisor | Joseph T. Coyle Yvon Lamour |
| Doctoral students | Elizabeth A. Buffalo |
| Signature | |
 | |
Joanne E. Berger-Sweeney (born September 21, 1958) is an American neuroscientist and the 22nd president of Trinity College, Hartford, Connecticut.[1] She is the first African-American and the first woman to serve in the position. Earlier in her career, Berger-Sweeney did proof-of-concept work on galantamine (brand name Razadyne), the second-most used drug to treat Alzheimer's disease.
- ^ "About President Berger-Sweeney". Trinity College. Retrieved May 29, 2019.